Efficacy and immune related adverse events in patients with melanoma treated with Ipilimumab
Latest Information Update: 05 Jan 2018
At a glance
- Drugs Ipilimumab (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Therapeutic Use
- 05 Jan 2018 New trial record